Pharmaceutical - Journal of Pharmaceutics & Pharmacology Lysosomotropic Action of Amantadine: Basis for Treatment of COVID-19 10 September 2020 Smieszek SP, Przychodzen BP, and Polymeropoulos MH The Sars-Cov-2 Viroporin E and its Interaction with Amantadine an Analysis 21 September 2020 Aranda-Abreu GE, Hernández-Aguilar ME, Herrera-Covarrubias D and Rojas-Durán F Amantadine for the Treatment of SARS-Cov-2: Case Report 21 September 2020 Aranda-Abreu GE, Aranda-Martínez JD and Araújo R Adamantanes for the Prevention of COVID-19: A Review of Case Reports 29 September 2020 Cortes Borra A Repurposing of Adamantanes for the Treatment of COVID-19: Rationale and Perspectives 16 September 2020 Butterworth Roger F Potential for the Use of Adamantanes for the Prevention and Treatment of the Neurological Complications of COVID-19 12 October 2020 Butterworth Roger F Repurposing of Adamantanes with Transmitter Receptor Antagonist Properties for the Prevention/Treatment of COVID-19 24 November 2020 Brenner SR and Butterworth RF Potential for the Repurposing of Adamantanes for the Treatment of Covid-19 24 November 2020 Roger F Butterworth Aticaprant (Clinically Developed Kappa-Opioid Receptor Antagonist) Combined With Naltrexone Prevents Alcohol “Relapse” Drinking 16 May 2022 Zhou Y, Zhou DC and Kreek MJ Inhibitory Effect of 5,7-Dimethoxyfl avone On Rosuvastatin Uptake From The Apical Membrane Of Caco-2 Cells 15 November 2022 Kimura O, Ohta C2, Koga N, Kato Y, Haraguchi K and Endo T